Dr. Jesse J. Jung, MD

Dr. Jung practices at East Bay Retina Consultants, Inc. in Oakland, California.

Dr. Jung's NPI, 1033351689, was assigned on March 28, 2009. Dr. Jung graduated from Emory School of Medicine in 2009. Dr. Jung holds California license A135262.

Dr. Jung's primary practice is East Bay Retina Consultants, Inc., at 3300 Telegraph Ave, Oakland, CA 94609-3028. The practice phone is (510) 444-1600.

Dr. Jung's primary practice is East Bay Retina Consultants, Inc. in Oakland, California. Dr. Jung is also affiliated with Alta Bates Summit Medical Center | Alta Bates Campus. The medical group on file is UCSF Department of Radiology & Biomedical Imaging. Dmand AI also links Dr. Jung to 1 more hospital and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Jung practices, 3 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Jung's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Jung is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Jung's licenses on file in 2 states: California and New York.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, dry eye, eyelid inflammation, glaucoma, hypertensive retinopathy and inflammation of iris among the conditions Dr. Jung treats.

CMS data shows 35,929 Medicare services from Dr. Jung across 19 procedure codes in 2024, for 987 Medicare patients. Medicare paid $2,181,037 for them. Every service was in an office.

CMS counts 987 Medicare patients who saw Dr. Jung in 2024. The largest group is 75 to 84, with 381 patients. 75% of them have high cholesterol, and 72% have high blood pressure. 17% are also on Medicaid. Their average risk score is 1.32, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Jung's median patient age at 70, with 53% women.

In 2024, Dr. Jung wrote 349 Medicare Part D claims for 86 patients. 60% of them were for generic drugs. CMS names the drug for 284 of them, across 9 drugs with 11 or more claims each, at $7,458 in total drug cost. In 2023, CMS named 216 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Jung for performance year 2024, reported as part of a group. Dr. Jung accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Cataract surgery: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 96 papers to Dr. Jung, published from 2004 to 2025. 2015 was the busiest year, with 7. The most frequent topics are Tomography, Optical Coherence, Visual Acuity and Fluorescein Angiography. Dr. Jung has published most often in Retina. Dr. Jung's most frequent co-authors are Soraya Rofagha, MD, Sucharita Boddu, MD and Srinivas Reddy Sadda, MD.

Dmand AI links Dr. Jung to 11 clinical trials, 7 of them phase 3 studies. Conditions studied include Macular Degeneration, Geographic Atrophy and Retinal Vein Occlusion. Hoffmann-La Roche sponsors the most, 3.

CMS Open Payments shows 188 general payments to Dr. Jung from 21 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 42% of the total. Carl Zeiss Meditec, Inc. paid the most, $47,671. It also lists 4 research payments totaling $4,963 from 2020 to 2023.

Dmand AI lists 19 awards for Dr. Jung, most recently Retina Society Member in 2021. Dr. Jung serves on John Muir Medical Center - Walnut Creek, California Academy of Eye Physicians and Surgeons and Hospital De La Familia Eye Center Nuevo Progresso San Marcos Guatemala.

Dr. Jung graduated from Emory School of Medicine in 2009. Dr. Jung is a member of AOA, AAO, ASRS, Asia-Pacific Ocular Imaging Society, California Academy of Eye Physicians and Surgeons and CMA.

Dr. Jung is in network with 14 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.